NEO, US64049M2098

NeoGenomics stock: NeoGenomics expands AI partnership. What it means for NeoGenomics stock

Published on 10/23/2026 at 01:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NeoGenomics will report third-quarter results on October 28, 2026. For NeoGenomics stock, preliminary revenue stood at USD 209 million.

AI infrastructure and upcoming results

On October 15, 2026, NeoGenomics expanded its Indica Labs partnership for digital pathology.
Second-quarter 2026 revenue reached USD 201.66 million, up 11.20 percent year over year.
NeoGenomics will report third-quarter 2026 results on October 28, 2026, at 4:30 p.m. ET.

NEO, US64049M2098, Illustration mit AI erstellt.

NeoGenomics (ISIN US64049M2098) expanded its partnership with Indica Labs on October 15, 2026, to scale AI-powered digital pathology. The collaboration uses Indica Labs' HALO AP platform to support a cloud-based image-management framework, according to Business Wire.

Digital pathology gets infrastructure

The expanded arrangement is designed to let NeoGenomics add third-party and internally developed artificial-intelligence tools while limiting integration costs. The company said its relationship with Indica Labs dates back to 2015, giving the latest announcement a ten-year operating history.

Revenue has a measurable base

NeoGenomics reported USD 201.66 million in revenue for the second quarter of 2026, up 11.20 percent from the same period a year earlier, while adjusted earnings per share reached USD 0.05 versus USD 0.03 consensus, according to MarketBeat. That comparison gives the digital-pathology investment a financial backdrop rather than leaving it as a technology-only announcement.

Three developments set the timeline

On October 5, 2026, NeoGenomics announced Warren Stone as CEO from January 4, 2027, and put preliminary third-quarter revenue at USD 209 million with NGS growth of 28 percent, according to NeoGenomics. On October 14, 2026, the company scheduled its third-quarter report for October 28, 2026, at 4:30 p.m. ET. On October 15, 2026, it expanded the Indica Labs partnership, whose technology relationship began in 2015.

Which dates matter next?

The next reporting date is October 28, 2026, after the U.S. market close, with the conference call at 4:30 p.m. ET, as stated by NeoGenomics. The leadership transition follows on January 4, 2027, when Stone is scheduled to become CEO and Tony Zook is scheduled to become Executive Chairman.

Stock context remains tied to execution

For investors, the central test is whether the planned digital infrastructure and leadership handover support the revenue trajectory already visible in the second quarter of 2026. The October 28 report should provide the next quantified update on the USD 209 million preliminary third-quarter revenue figure.